These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38944863)

  • 41. Fecal calprotectin evaluation in patients with ulcerative colitis.
    Dogan T; Agilli M
    Dig Dis Sci; 2015 Apr; 60(4):1109-10. PubMed ID: 25586087
    [No Abstract]   [Full Text] [Related]  

  • 42. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
    Jusué V; Chaparro M; Gisbert JP
    Dig Liver Dis; 2018 Apr; 50(4):353-359. PubMed ID: 29396129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy].
    Knyazev OV; Khomeriki SG; Kagramanova AV; Lishchinskaya AA; Smirnova OA; Noskova KK; Parfenov AI
    Ter Arkh; 2021 Dec; 93(12):1435-1442. PubMed ID: 36286670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab.
    Magro F; Lopes SI; Lopes J; Portela F; Cotter J; Lopes S; Moreira MJ; Lago P; Peixe P; Albuquerque A; Rodrigues S; Silva MR; Monteiro P; Lopes C; Monteiro L; Macedo G; Veloso L; Camila C; Afonso J; Geboes K; Carneiro F;
    J Crohns Colitis; 2016 Dec; 10(12):1407-1416. PubMed ID: 27226417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of
    Li Y; Khamou M; Schaarschmidt BM; Umutlu L; Forsting M; Demircioglu A; Haubold J; Koch AK; Bruckmann NM; Sawicki LM; Herrmann K; Boone JH; Langhorst J
    Br J Radiol; 2020 Aug; 93(1112):20200167. PubMed ID: 32579403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fecal calprotectin levels predict the clinical course in patients with new onset of ulcerative colitis.
    Lasson A; Simrén M; Stotzer PO; Isaksson S; Ohman L; Strid H
    Inflamm Bowel Dis; 2013 Mar; 19(3):576-81. PubMed ID: 23377170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study.
    Shimoyama T; Yamamoto T; Umegae S; Matsumoto K
    BMC Gastroenterol; 2018 Aug; 18(1):120. PubMed ID: 30068300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
    Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
    J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis.
    Lobatón T; Rodríguez-Moranta F; Lopez A; Sánchez E; Rodríguez-Alonso L; Guardiola J
    Inflamm Bowel Dis; 2013 Apr; 19(5):1034-42. PubMed ID: 23470502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive value of faecal calprotectin in ulcerative colitis - single centre experience.
    Grgić D; Golubić K; Brinar M; Krznarić Ž
    Ann Med; 2022 Dec; 54(1):1570-1577. PubMed ID: 35635011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis.
    Hassan EA; Ramadan HK; Ismael AA; Mohamed KF; El-Attar MM; Alhelali I
    Saudi J Gastroenterol; 2017; 23(4):238-245. PubMed ID: 28721978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Limitations of the determination of faecal calprotectin in patients with ulcerative colitis and inflammatory polyps.
    Bermejo F; Algaba A; Bonillo D; Jiménez L; Guardiola-Arévalo A; Pacheco M; Castaño Á; Guerra I
    Gastroenterol Hepatol; 2020 Feb; 43(2):73-78. PubMed ID: 31648810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis.
    Dulai PS; Feagan BG; Sands BE; Chen J; Lasch K; Lirio RA
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):456-466.e7. PubMed ID: 35934286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.
    Magro F; Lopes S; Coelho R; Cotter J; Dias de Castro F; Tavares de Sousa H; Salgado M; Andrade P; Vieira AI; Figueiredo P; Caldeira P; Sousa A; Duarte MA; Ávila F; Silva J; Moleiro J; Mendes S; Giestas S; Ministro P; Sousa P; Gonçalves R; Gonçalves B; Oliveira A; Chagas C; Torres J; Dias CC; Lopes J; Borralho P; Afonso J; Geboes K; Carneiro F;
    J Crohns Colitis; 2017 Apr; 11(4):435-444. PubMed ID: 27664275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Patel A; Panchal H; Dubinsky MC
    Inflamm Bowel Dis; 2017 Sep; 23(9):1600-1604. PubMed ID: 28590341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis.
    Scaioli E; Sartini A; Bellanova M; Campieri M; Festi D; Bazzoli F; Belluzzi A
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1268-1275.e2. PubMed ID: 29391271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fecal calprotectin-guided dosing of mesalamine in ulcerative colitis: concept proved but more data needed.
    Vande Casteele N; Sandborn WJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1894-6. PubMed ID: 24951843
    [No Abstract]   [Full Text] [Related]  

  • 60. Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFα Antagonists.
    Tursi A; Elisei W; Picchio M; Giorgetti G; Brandimarte G
    Dig Dis Sci; 2015 May; 60(5):1406-13. PubMed ID: 25445163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.